User profiles for "author:Gabrielle Norrish"

Gabrielle Norrish

Academic clinical lecturer, Institute of Cardiovascular science, University College London
Verified email at ucl.ac.uk
Cited by 991

Risk factors for sudden cardiac death in childhood hypertrophic cardiomyopathy: a systematic review and meta-analysis

G Norrish, N Cantarutti, E Pissaridou… - European journal of …, 2017 - academic.oup.com
Aims To perform a systematic literature review and meta-analysis of clinical risk factors for
sudden cardiac death (SCD) in childhood hypertrophic cardiomyopathy. Methods Medline …

Development of a novel risk prediction model for sudden cardiac death in childhood hypertrophic cardiomyopathy (HCM Risk-Kids)

G Norrish, T Ding, E Field, L Ziółkowska… - JAMA …, 2019 - jamanetwork.com
Importance Sudden cardiac death (SCD) is the most common mode of death in childhood
hypertrophic cardiomyopathy (HCM), but there is no validated algorithm to identify those at …

Penetrance of hypertrophic cardiomyopathy in sarcomere protein mutation carriers

M Lorenzini, G Norrish, E Field, JP Ochoa… - Journal of the American …, 2020 - jacc.org
Background Predictive genetic screening of relatives of patients with hypertrophic
cardiomyopathy (HCM) caused by sarcomere protein (SP) gene mutations is current …

Calmodulin mutations and life-threatening cardiac arrhythmias: insights from the International Calmodulinopathy Registry

L Crotti, C Spazzolini, DJ Tester, A Ghidoni… - European heart …, 2019 - academic.oup.com
Aims Calmodulinopathies are rare life-threatening arrhythmia syndromes which affect mostly
young individuals and are, caused by mutations in any of the three genes (CALM 1–3) that …

[HTML][HTML] Childhood hypertrophic cardiomyopathy: a disease of the cardiac sarcomere

G Norrish, E Field, JP Kaski - Frontiers in Pediatrics, 2021 - frontiersin.org
Hypertrophic cardiomyopathy is the second most common cause of cardiomyopathy
presenting during childhood and whilst its underlying aetiology is variable, the majority of …

Clinical presentation and survival of childhood hypertrophic cardiomyopathy: a retrospective study in United Kingdom

G Norrish, E Field, K Mcleod, M Ilina… - European heart …, 2019 - academic.oup.com
Aims Understanding the spectrum of disease, symptom burden and natural history are
essential for the management of children with hypertrophic cardiomyopathy (HCM). The …

External validation of the HCM Risk-Kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathy

G Norrish, C Qu, E Field, E Cervi… - European journal of …, 2022 - academic.oup.com
Aims Sudden cardiac death (SCD) is the most common mode of death in childhood
hypertrophic cardiomyopathy (HCM). The newly developed HCM Risk-Kids model provides …

Yield of clinical screening for hypertrophic cardiomyopathy in child first-degree relatives: evidence for a change in paradigm

G Norrish, J Jager, E Field, E Quinn, H Fell, E Lord… - Circulation, 2019 - Am Heart Assoc
Background: Hypertrophic cardiomyopathy (HCM) is a heritable myocardial disease with
age-related penetrance. Current guidelines recommend clinical screening of relatives …

Clinical features and natural history of preadolescent nonsyndromic hypertrophic cardiomyopathy

G Norrish, A Cleary, E Field, E Cervi, O Boleti… - Journal of the American …, 2022 - jacc.org
Background Up to one-half of childhood sarcomeric hypertrophic cardiomyopathy (HCM)
presents before the age of 12 years, but this patient group has not been systematically …

The risk of sudden death in children with hypertrophic cardiomyopathy

G Norrish, JP Kaski - Heart Failure Clinics, 2022 - heartfailure.theclinics.com
Hypertrophic cardiomyopathy (HCM) is defined as left ventricular hypertrophy (LVH) in the
absence of abnormal loading conditions. 1 The prevalence of HCM during childhood is …